nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CYP3A5—Tacrolimus—atopic dermatitis	0.0336	0.0986	CbGbCtD
Dasatinib—CYP1B1—Dexamethasone—atopic dermatitis	0.0323	0.0948	CbGbCtD
Dasatinib—ABCG2—Hydrocortisone—atopic dermatitis	0.0247	0.0724	CbGbCtD
Dasatinib—CYP3A4—Pimecrolimus—atopic dermatitis	0.022	0.0646	CbGbCtD
Dasatinib—ABCB1—Tacrolimus—atopic dermatitis	0.0219	0.0642	CbGbCtD
Dasatinib—CYP1A2—Diphenhydramine—atopic dermatitis	0.0183	0.0537	CbGbCtD
Dasatinib—FMO3—sweat—atopic dermatitis	0.0176	0.15	CbGeAlD
Dasatinib—ABCB1—Loratadine—atopic dermatitis	0.016	0.047	CbGbCtD
Dasatinib—ABCG2—Dexamethasone—atopic dermatitis	0.0154	0.0451	CbGbCtD
Dasatinib—ABCB1—Methylprednisolone—atopic dermatitis	0.0146	0.043	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—atopic dermatitis	0.0142	0.0416	CbGbCtD
Dasatinib—CYP3A5—Hydrocortisone—atopic dermatitis	0.0137	0.0401	CbGbCtD
Dasatinib—CYP3A4—Tacrolimus—atopic dermatitis	0.0131	0.0384	CbGbCtD
Dasatinib—CYP3A4—Loratadine—atopic dermatitis	0.00959	0.0281	CbGbCtD
Dasatinib—ABCB1—Betamethasone—atopic dermatitis	0.00952	0.0279	CbGbCtD
Dasatinib—ABCB1—Prednisolone—atopic dermatitis	0.00939	0.0276	CbGbCtD
Dasatinib—ABCB1—Hydrocortisone—atopic dermatitis	0.0089	0.0261	CbGbCtD
Dasatinib—ABCB1—Prednisone—atopic dermatitis	0.00887	0.026	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—atopic dermatitis	0.00877	0.0257	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—atopic dermatitis	0.00851	0.025	CbGbCtD
Dasatinib—PTK6—skin epidermis—atopic dermatitis	0.00794	0.068	CbGeAlD
Dasatinib—CYP3A4—Triamcinolone—atopic dermatitis	0.00665	0.0195	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—atopic dermatitis	0.0057	0.0167	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—atopic dermatitis	0.00563	0.0165	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—atopic dermatitis	0.00554	0.0162	CbGbCtD
Dasatinib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00533	0.0157	CbGbCtD
Dasatinib—CYP3A4—Prednisone—atopic dermatitis	0.00531	0.0156	CbGbCtD
Dasatinib—PKMYT1—neck—atopic dermatitis	0.00416	0.0356	CbGeAlD
Dasatinib—CYP3A4—Dexamethasone—atopic dermatitis	0.00332	0.00973	CbGbCtD
Dasatinib—MYT1—head—atopic dermatitis	0.00306	0.0262	CbGeAlD
Dasatinib—KIT—skin epidermis—atopic dermatitis	0.00276	0.0237	CbGeAlD
Dasatinib—BMX—skin of body—atopic dermatitis	0.00263	0.0225	CbGeAlD
Dasatinib—PTK6—skin of body—atopic dermatitis	0.00246	0.0211	CbGeAlD
Dasatinib—STAT5B—skin of body—atopic dermatitis	0.00233	0.0199	CbGeAlD
Dasatinib—EPHB1—head—atopic dermatitis	0.00204	0.0175	CbGeAlD
Dasatinib—MAPK14—neck—atopic dermatitis	0.00201	0.0172	CbGeAlD
Dasatinib—SIK2—head—atopic dermatitis	0.0018	0.0154	CbGeAlD
Dasatinib—PKMYT1—head—atopic dermatitis	0.00176	0.015	CbGeAlD
Dasatinib—EPHB2—head—atopic dermatitis	0.00167	0.0143	CbGeAlD
Dasatinib—SRMS—head—atopic dermatitis	0.00164	0.014	CbGeAlD
Dasatinib—TXK—head—atopic dermatitis	0.00162	0.0139	CbGeAlD
Dasatinib—EPHA8—head—atopic dermatitis	0.00161	0.0137	CbGeAlD
Dasatinib—STK35—skin of body—atopic dermatitis	0.00159	0.0136	CbGeAlD
Dasatinib—CSK—skin of body—atopic dermatitis	0.00158	0.0135	CbGeAlD
Dasatinib—STAT5B—head—atopic dermatitis	0.00152	0.013	CbGeAlD
Dasatinib—RIPK2—skin of body—atopic dermatitis	0.00146	0.0125	CbGeAlD
Dasatinib—CYP1A1—skin epidermis—atopic dermatitis	0.00144	0.0123	CbGeAlD
Dasatinib—SIK1—skin of body—atopic dermatitis	0.00143	0.0122	CbGeAlD
Dasatinib—EPHA3—head—atopic dermatitis	0.0014	0.012	CbGeAlD
Dasatinib—ERBB3—skin of body—atopic dermatitis	0.0014	0.012	CbGeAlD
Dasatinib—SIK3—head—atopic dermatitis	0.00137	0.0117	CbGeAlD
Dasatinib—KIT—neck—atopic dermatitis	0.00132	0.0113	CbGeAlD
Dasatinib—MAPK14—skin of body—atopic dermatitis	0.0013	0.0112	CbGeAlD
Dasatinib—PDGFRB—neck—atopic dermatitis	0.00129	0.0111	CbGeAlD
Dasatinib—ZAK—head—atopic dermatitis	0.00127	0.0109	CbGeAlD
Dasatinib—EPHA5—head—atopic dermatitis	0.00124	0.0106	CbGeAlD
Dasatinib—LYN—head—atopic dermatitis	0.00124	0.0106	CbGeAlD
Dasatinib—JAK2—skin of body—atopic dermatitis	0.00123	0.0105	CbGeAlD
Dasatinib—BMPR1B—head—atopic dermatitis	0.00122	0.0104	CbGeAlD
Dasatinib—MAP3K19—head—atopic dermatitis	0.00122	0.0104	CbGeAlD
Dasatinib—FYN—skin of body—atopic dermatitis	0.00121	0.0104	CbGeAlD
Dasatinib—TNK2—head—atopic dermatitis	0.00119	0.0102	CbGeAlD
Dasatinib—MAP3K3—skin of body—atopic dermatitis	0.00118	0.0101	CbGeAlD
Dasatinib—EPHB6—skin of body—atopic dermatitis	0.00113	0.00967	CbGeAlD
Dasatinib—TESK1—head—atopic dermatitis	0.00112	0.0096	CbGeAlD
Dasatinib—STK36—head—atopic dermatitis	0.0011	0.00945	CbGeAlD
Dasatinib—EPHB3—head—atopic dermatitis	0.0011	0.00945	CbGeAlD
Dasatinib—LIMK2—head—atopic dermatitis	0.00107	0.00914	CbGeAlD
Dasatinib—SRC—skin of body—atopic dermatitis	0.00105	0.00899	CbGeAlD
Dasatinib—STK35—head—atopic dermatitis	0.00103	0.00886	CbGeAlD
Dasatinib—CSK—head—atopic dermatitis	0.00103	0.0088	CbGeAlD
Dasatinib—HCK—head—atopic dermatitis	0.00101	0.00868	CbGeAlD
Dasatinib—RIPK2—head—atopic dermatitis	0.000954	0.00817	CbGeAlD
Dasatinib—CSF1R—skin of body—atopic dermatitis	0.000943	0.00807	CbGeAlD
Dasatinib—SIK1—head—atopic dermatitis	0.000932	0.00797	CbGeAlD
Dasatinib—EPHA4—head—atopic dermatitis	0.000922	0.00789	CbGeAlD
Dasatinib—ERBB3—head—atopic dermatitis	0.000913	0.00782	CbGeAlD
Dasatinib—MAP3K2—head—atopic dermatitis	0.000904	0.00774	CbGeAlD
Dasatinib—KIT—skin of body—atopic dermatitis	0.000856	0.00733	CbGeAlD
Dasatinib—MAPK14—head—atopic dermatitis	0.00085	0.00728	CbGeAlD
Dasatinib—FGR—head—atopic dermatitis	0.000847	0.00725	CbGeAlD
Dasatinib—PDGFRB—skin of body—atopic dermatitis	0.000836	0.00716	CbGeAlD
Dasatinib—FMO3—head—atopic dermatitis	0.000818	0.007	CbGeAlD
Dasatinib—JAK2—head—atopic dermatitis	0.0008	0.00685	CbGeAlD
Dasatinib—EPHA2—head—atopic dermatitis	0.000791	0.00677	CbGeAlD
Dasatinib—FYN—head—atopic dermatitis	0.000789	0.00676	CbGeAlD
Dasatinib—MAP4K5—head—atopic dermatitis	0.000771	0.0066	CbGeAlD
Dasatinib—MAP3K3—head—atopic dermatitis	0.000771	0.0066	CbGeAlD
Dasatinib—ABL1—skin of body—atopic dermatitis	0.000745	0.00638	CbGeAlD
Dasatinib—EPHB6—head—atopic dermatitis	0.000737	0.00631	CbGeAlD
Dasatinib—YES1—head—atopic dermatitis	0.000712	0.0061	CbGeAlD
Dasatinib—PDGFRA—head—atopic dermatitis	0.000699	0.00598	CbGeAlD
Dasatinib—SRC—head—atopic dermatitis	0.000685	0.00587	CbGeAlD
Dasatinib—CYP1B1—skin of body—atopic dermatitis	0.000631	0.0054	CbGeAlD
Dasatinib—MAP2K5—head—atopic dermatitis	0.00063	0.0054	CbGeAlD
Dasatinib—CSF1R—head—atopic dermatitis	0.000615	0.00527	CbGeAlD
Dasatinib—KIT—head—atopic dermatitis	0.000559	0.00478	CbGeAlD
Dasatinib—PDGFRB—head—atopic dermatitis	0.000546	0.00467	CbGeAlD
Dasatinib—ABL1—head—atopic dermatitis	0.000486	0.00416	CbGeAlD
Dasatinib—CSK—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000469	0.066	CbGdCrCtD
Dasatinib—CSK—Everolimus—Pimecrolimus—atopic dermatitis	0.000469	0.066	CbGdCrCtD
Dasatinib—CSK—Sirolimus—Pimecrolimus—atopic dermatitis	0.000469	0.066	CbGdCrCtD
Dasatinib—CSK—Everolimus—Tacrolimus—atopic dermatitis	0.000469	0.066	CbGdCrCtD
Dasatinib—CSK—Temsirolimus—Tacrolimus—atopic dermatitis	0.000469	0.066	CbGdCrCtD
Dasatinib—CSK—Sirolimus—Tacrolimus—atopic dermatitis	0.000469	0.066	CbGdCrCtD
Dasatinib—CYP1A1—skin of body—atopic dermatitis	0.000446	0.00382	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Desonide—atopic dermatitis	0.000425	0.0598	CbGdCrCtD
Dasatinib—CYP1B1—head—atopic dermatitis	0.000412	0.00353	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Fluocinonide—atopic dermatitis	0.000341	0.0479	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Fluocinolone Acetonide—atopic dermatitis	0.000331	0.0466	CbGdCrCtD
Dasatinib—CYP1A1—head—atopic dermatitis	0.000291	0.00249	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Mometasone—atopic dermatitis	0.000264	0.0372	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Desonide—atopic dermatitis	0.000173	0.0243	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Desonide—atopic dermatitis	0.000173	0.0243	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—atopic dermatitis	0.000158	0.0222	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—atopic dermatitis	0.000155	0.0218	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Betamethasone—atopic dermatitis	0.000155	0.0218	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—atopic dermatitis	0.000152	0.0213	CbGdCrCtD
Dasatinib—ABCB1—head—atopic dermatitis	0.000151	0.00129	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisone—atopic dermatitis	0.000144	0.0203	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Prednisolone—atopic dermatitis	0.00014	0.0198	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Fluocinonide—atopic dermatitis	0.000138	0.0195	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Fluocinonide—atopic dermatitis	0.000138	0.0195	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000135	0.0189	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000135	0.0189	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Mometasone—atopic dermatitis	0.000107	0.0151	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Mometasone—atopic dermatitis	0.000107	0.0151	CbGdCrCtD
Dasatinib—Syncope—Triamcinolone—atopic dermatitis	0.000105	0.000377	CcSEcCtD
Dasatinib—Vertigo—Methylprednisolone—atopic dermatitis	0.000105	0.000377	CcSEcCtD
Dasatinib—Syncope—Methylprednisolone—atopic dermatitis	0.000104	0.000376	CcSEcCtD
Dasatinib—Discomfort—Hydrocortisone—atopic dermatitis	0.000104	0.000376	CcSEcCtD
Dasatinib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000104	0.000375	CcSEcCtD
Dasatinib—Oedema—Prednisolone—atopic dermatitis	0.000103	0.000373	CcSEcCtD
Dasatinib—Vomiting—Tacrolimus—atopic dermatitis	0.000103	0.000371	CcSEcCtD
Dasatinib—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000102	0.00037	CcSEcCtD
Dasatinib—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000102	0.000369	CcSEcCtD
Dasatinib—Rash—Tacrolimus—atopic dermatitis	0.000102	0.000368	CcSEcCtD
Dasatinib—Dermatitis—Tacrolimus—atopic dermatitis	0.000102	0.000368	CcSEcCtD
Dasatinib—Shock—Prednisolone—atopic dermatitis	0.000102	0.000367	CcSEcCtD
Dasatinib—Cough—Triamcinolone—atopic dermatitis	0.000102	0.000367	CcSEcCtD
Dasatinib—Headache—Tacrolimus—atopic dermatitis	0.000101	0.000366	CcSEcCtD
Dasatinib—Oedema—Hydrocortisone—atopic dermatitis	0.000101	0.000364	CcSEcCtD
Dasatinib—Convulsion—Triamcinolone—atopic dermatitis	0.000101	0.000364	CcSEcCtD
Dasatinib—Tachycardia—Prednisolone—atopic dermatitis	0.000101	0.000364	CcSEcCtD
Dasatinib—Convulsion—Methylprednisolone—atopic dermatitis	0.000101	0.000364	CcSEcCtD
Dasatinib—Hypertension—Triamcinolone—atopic dermatitis	0.000101	0.000363	CcSEcCtD
Dasatinib—Hypertension—Methylprednisolone—atopic dermatitis	0.0001	0.000362	CcSEcCtD
Dasatinib—Infection—Hydrocortisone—atopic dermatitis	0.0001	0.000362	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisolone—atopic dermatitis	0.0001	0.000361	CcSEcCtD
Dasatinib—Shock—Hydrocortisone—atopic dermatitis	9.94e-05	0.000359	CcSEcCtD
Dasatinib—Myalgia—Triamcinolone—atopic dermatitis	9.92e-05	0.000358	CcSEcCtD
Dasatinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	9.91e-05	0.000357	CcSEcCtD
Dasatinib—Arthralgia—Methylprednisolone—atopic dermatitis	9.9e-05	0.000357	CcSEcCtD
Dasatinib—Myalgia—Methylprednisolone—atopic dermatitis	9.9e-05	0.000357	CcSEcCtD
Dasatinib—Eye disorder—Prednisone—atopic dermatitis	9.89e-05	0.000357	CcSEcCtD
Dasatinib—Anxiety—Methylprednisolone—atopic dermatitis	9.87e-05	0.000356	CcSEcCtD
Dasatinib—Tachycardia—Hydrocortisone—atopic dermatitis	9.86e-05	0.000356	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	9.83e-05	0.000355	CcSEcCtD
Dasatinib—Flushing—Prednisone—atopic dermatitis	9.82e-05	0.000354	CcSEcCtD
Dasatinib—Skin disorder—Hydrocortisone—atopic dermatitis	9.81e-05	0.000354	CcSEcCtD
Dasatinib—Ill-defined disorder—Betamethasone—atopic dermatitis	9.81e-05	0.000354	CcSEcCtD
Dasatinib—Ill-defined disorder—Dexamethasone—atopic dermatitis	9.81e-05	0.000354	CcSEcCtD
Dasatinib—Discomfort—Triamcinolone—atopic dermatitis	9.81e-05	0.000354	CcSEcCtD
Dasatinib—Discomfort—Methylprednisolone—atopic dermatitis	9.78e-05	0.000353	CcSEcCtD
Dasatinib—Hyperhidrosis—Hydrocortisone—atopic dermatitis	9.77e-05	0.000352	CcSEcCtD
Dasatinib—Anorexia—Hydrocortisone—atopic dermatitis	9.63e-05	0.000347	CcSEcCtD
Dasatinib—Nausea—Tacrolimus—atopic dermatitis	9.62e-05	0.000347	CcSEcCtD
Dasatinib—Angiopathy—Prednisone—atopic dermatitis	9.6e-05	0.000346	CcSEcCtD
Dasatinib—Confusional state—Methylprednisolone—atopic dermatitis	9.57e-05	0.000345	CcSEcCtD
Dasatinib—Immune system disorder—Prednisone—atopic dermatitis	9.56e-05	0.000345	CcSEcCtD
Dasatinib—Malaise—Dexamethasone—atopic dermatitis	9.54e-05	0.000344	CcSEcCtD
Dasatinib—Malaise—Betamethasone—atopic dermatitis	9.54e-05	0.000344	CcSEcCtD
Dasatinib—Oedema—Triamcinolone—atopic dermatitis	9.51e-05	0.000343	CcSEcCtD
Dasatinib—Vertigo—Dexamethasone—atopic dermatitis	9.5e-05	0.000343	CcSEcCtD
Dasatinib—Vertigo—Betamethasone—atopic dermatitis	9.5e-05	0.000343	CcSEcCtD
Dasatinib—Syncope—Betamethasone—atopic dermatitis	9.49e-05	0.000342	CcSEcCtD
Dasatinib—Syncope—Dexamethasone—atopic dermatitis	9.49e-05	0.000342	CcSEcCtD
Dasatinib—PKMYT1—Danazol—Hydrocortisone—atopic dermatitis	9.49e-05	0.0133	CbGdCrCtD
Dasatinib—Arrhythmia—Prednisone—atopic dermatitis	9.45e-05	0.000341	CcSEcCtD
Dasatinib—Infection—Triamcinolone—atopic dermatitis	9.45e-05	0.000341	CcSEcCtD
Dasatinib—Hypotension—Hydrocortisone—atopic dermatitis	9.44e-05	0.000341	CcSEcCtD
Dasatinib—Infection—Methylprednisolone—atopic dermatitis	9.43e-05	0.00034	CcSEcCtD
Dasatinib—Shock—Triamcinolone—atopic dermatitis	9.36e-05	0.000338	CcSEcCtD
Dasatinib—Insomnia—Prednisolone—atopic dermatitis	9.36e-05	0.000338	CcSEcCtD
Dasatinib—Alopecia—Prednisone—atopic dermatitis	9.35e-05	0.000337	CcSEcCtD
Dasatinib—Shock—Methylprednisolone—atopic dermatitis	9.34e-05	0.000337	CcSEcCtD
Dasatinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	9.31e-05	0.000336	CcSEcCtD
Dasatinib—Loss of consciousness—Betamethasone—atopic dermatitis	9.3e-05	0.000335	CcSEcCtD
Dasatinib—Loss of consciousness—Dexamethasone—atopic dermatitis	9.3e-05	0.000335	CcSEcCtD
Dasatinib—Tachycardia—Triamcinolone—atopic dermatitis	9.29e-05	0.000335	CcSEcCtD
Dasatinib—Mental disorder—Prednisone—atopic dermatitis	9.27e-05	0.000334	CcSEcCtD
Dasatinib—Tachycardia—Methylprednisolone—atopic dermatitis	9.26e-05	0.000334	CcSEcCtD
Dasatinib—Skin disorder—Methylprednisolone—atopic dermatitis	9.22e-05	0.000333	CcSEcCtD
Dasatinib—Erythema—Prednisone—atopic dermatitis	9.21e-05	0.000332	CcSEcCtD
Dasatinib—Malnutrition—Prednisone—atopic dermatitis	9.21e-05	0.000332	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	9.21e-05	0.000332	CcSEcCtD
Dasatinib—Hyperhidrosis—Triamcinolone—atopic dermatitis	9.2e-05	0.000332	CcSEcCtD
Dasatinib—Hyperhidrosis—Methylprednisolone—atopic dermatitis	9.18e-05	0.000331	CcSEcCtD
Dasatinib—Convulsion—Betamethasone—atopic dermatitis	9.16e-05	0.000331	CcSEcCtD
Dasatinib—Convulsion—Dexamethasone—atopic dermatitis	9.16e-05	0.000331	CcSEcCtD
Dasatinib—Insomnia—Hydrocortisone—atopic dermatitis	9.14e-05	0.00033	CcSEcCtD
Dasatinib—Hypertension—Dexamethasone—atopic dermatitis	9.13e-05	0.000329	CcSEcCtD
Dasatinib—Hypertension—Betamethasone—atopic dermatitis	9.13e-05	0.000329	CcSEcCtD
Dasatinib—Myalgia—Betamethasone—atopic dermatitis	9.01e-05	0.000325	CcSEcCtD
Dasatinib—Myalgia—Dexamethasone—atopic dermatitis	9.01e-05	0.000325	CcSEcCtD
Dasatinib—Anxiety—Betamethasone—atopic dermatitis	8.97e-05	0.000324	CcSEcCtD
Dasatinib—Anxiety—Dexamethasone—atopic dermatitis	8.97e-05	0.000324	CcSEcCtD
Dasatinib—Discomfort—Dexamethasone—atopic dermatitis	8.9e-05	0.000321	CcSEcCtD
Dasatinib—Discomfort—Betamethasone—atopic dermatitis	8.9e-05	0.000321	CcSEcCtD
Dasatinib—Dyspepsia—Hydrocortisone—atopic dermatitis	8.89e-05	0.000321	CcSEcCtD
Dasatinib—Hypotension—Methylprednisolone—atopic dermatitis	8.87e-05	0.00032	CcSEcCtD
Dasatinib—Pain—Prednisolone—atopic dermatitis	8.85e-05	0.000319	CcSEcCtD
Dasatinib—Decreased appetite—Hydrocortisone—atopic dermatitis	8.78e-05	0.000317	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	8.72e-05	0.000315	CcSEcCtD
Dasatinib—Fatigue—Hydrocortisone—atopic dermatitis	8.71e-05	0.000314	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—atopic dermatitis	8.68e-05	0.000313	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	8.67e-05	0.000313	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	8.65e-05	0.000312	CcSEcCtD
Dasatinib—Pain—Hydrocortisone—atopic dermatitis	8.64e-05	0.000312	CcSEcCtD
Dasatinib—Oedema—Betamethasone—atopic dermatitis	8.63e-05	0.000311	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—atopic dermatitis	8.63e-05	0.000311	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—atopic dermatitis	8.6e-05	0.00031	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—atopic dermatitis	8.59e-05	0.00031	CcSEcCtD
Dasatinib—Infection—Dexamethasone—atopic dermatitis	8.58e-05	0.000309	CcSEcCtD
Dasatinib—Infection—Betamethasone—atopic dermatitis	8.58e-05	0.000309	CcSEcCtD
Dasatinib—Ill-defined disorder—Prednisone—atopic dermatitis	8.55e-05	0.000308	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—atopic dermatitis	8.53e-05	0.000308	CcSEcCtD
Dasatinib—Anaemia—Prednisone—atopic dermatitis	8.51e-05	0.000307	CcSEcCtD
Dasatinib—Shock—Betamethasone—atopic dermatitis	8.49e-05	0.000306	CcSEcCtD
Dasatinib—Shock—Dexamethasone—atopic dermatitis	8.49e-05	0.000306	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—atopic dermatitis	8.48e-05	0.000306	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—atopic dermatitis	8.47e-05	0.000305	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—atopic dermatitis	8.47e-05	0.000305	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—atopic dermatitis	8.45e-05	0.000305	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—atopic dermatitis	8.45e-05	0.000305	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—atopic dermatitis	8.43e-05	0.000304	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—atopic dermatitis	8.43e-05	0.000304	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—atopic dermatitis	8.37e-05	0.000302	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—atopic dermatitis	8.36e-05	0.000301	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—atopic dermatitis	8.35e-05	0.000301	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—atopic dermatitis	8.35e-05	0.000301	CcSEcCtD
Dasatinib—Feeling abnormal—Hydrocortisone—atopic dermatitis	8.33e-05	0.0003	CcSEcCtD
Dasatinib—Malaise—Prednisone—atopic dermatitis	8.31e-05	0.0003	CcSEcCtD
Dasatinib—Vertigo—Prednisone—atopic dermatitis	8.28e-05	0.000299	CcSEcCtD
Dasatinib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	8.26e-05	0.000298	CcSEcCtD
Dasatinib—Syncope—Prednisone—atopic dermatitis	8.26e-05	0.000298	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—atopic dermatitis	8.23e-05	0.000297	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—atopic dermatitis	8.23e-05	0.000297	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—atopic dermatitis	8.22e-05	0.000296	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—atopic dermatitis	8.2e-05	0.000296	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—atopic dermatitis	8.18e-05	0.000295	CcSEcCtD
Dasatinib—PKMYT1—Danazol—Prednisone—atopic dermatitis	8.17e-05	0.0115	CbGdCrCtD
Dasatinib—Pain—Triamcinolone—atopic dermatitis	8.14e-05	0.000293	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—atopic dermatitis	8.1e-05	0.000292	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—atopic dermatitis	8.07e-05	0.000291	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—atopic dermatitis	8.07e-05	0.000291	CcSEcCtD
Dasatinib—Urticaria—Hydrocortisone—atopic dermatitis	8.03e-05	0.00029	CcSEcCtD
Dasatinib—Abdominal pain—Hydrocortisone—atopic dermatitis	7.99e-05	0.000288	CcSEcCtD
Dasatinib—Body temperature increased—Hydrocortisone—atopic dermatitis	7.99e-05	0.000288	CcSEcCtD
Dasatinib—Convulsion—Prednisone—atopic dermatitis	7.98e-05	0.000288	CcSEcCtD
Dasatinib—Hypertension—Prednisone—atopic dermatitis	7.95e-05	0.000287	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	7.86e-05	0.000284	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	7.86e-05	0.000284	CcSEcCtD
Dasatinib—Myalgia—Prednisone—atopic dermatitis	7.84e-05	0.000283	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—atopic dermatitis	7.84e-05	0.000283	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—atopic dermatitis	7.84e-05	0.000283	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—atopic dermatitis	7.82e-05	0.000282	CcSEcCtD
Dasatinib—Anxiety—Prednisone—atopic dermatitis	7.82e-05	0.000282	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—atopic dermatitis	7.81e-05	0.000282	CcSEcCtD
Dasatinib—Insomnia—Betamethasone—atopic dermatitis	7.81e-05	0.000282	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	7.79e-05	0.000281	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	7.76e-05	0.00028	CcSEcCtD
Dasatinib—Discomfort—Prednisone—atopic dermatitis	7.75e-05	0.00028	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—atopic dermatitis	7.62e-05	0.000275	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—atopic dermatitis	7.6e-05	0.000274	CcSEcCtD
Dasatinib—Dyspepsia—Betamethasone—atopic dermatitis	7.6e-05	0.000274	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—atopic dermatitis	7.56e-05	0.000273	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—atopic dermatitis	7.54e-05	0.000272	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—atopic dermatitis	7.52e-05	0.000271	CcSEcCtD
Dasatinib—Oedema—Prednisone—atopic dermatitis	7.52e-05	0.000271	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—atopic dermatitis	7.5e-05	0.000271	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—atopic dermatitis	7.5e-05	0.000271	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—atopic dermatitis	7.5e-05	0.000271	CcSEcCtD
Dasatinib—Infection—Prednisone—atopic dermatitis	7.47e-05	0.000269	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	7.45e-05	0.000269	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	7.45e-05	0.000269	CcSEcCtD
Dasatinib—Hypersensitivity—Hydrocortisone—atopic dermatitis	7.44e-05	0.000269	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—atopic dermatitis	7.44e-05	0.000268	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—atopic dermatitis	7.44e-05	0.000268	CcSEcCtD
Dasatinib—Shock—Prednisone—atopic dermatitis	7.4e-05	0.000267	CcSEcCtD
Dasatinib—Pain—Dexamethasone—atopic dermatitis	7.38e-05	0.000266	CcSEcCtD
Dasatinib—Pain—Betamethasone—atopic dermatitis	7.38e-05	0.000266	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—atopic dermatitis	7.37e-05	0.000266	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—atopic dermatitis	7.34e-05	0.000265	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—atopic dermatitis	7.3e-05	0.000263	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—atopic dermatitis	7.27e-05	0.000262	CcSEcCtD
Dasatinib—Asthenia—Hydrocortisone—atopic dermatitis	7.25e-05	0.000262	CcSEcCtD
Dasatinib—Anorexia—Prednisone—atopic dermatitis	7.17e-05	0.000258	CcSEcCtD
Dasatinib—Pruritus—Hydrocortisone—atopic dermatitis	7.15e-05	0.000258	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—atopic dermatitis	7.11e-05	0.000257	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—atopic dermatitis	7.11e-05	0.000257	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.06e-05	0.000255	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.06e-05	0.000255	CcSEcCtD
Dasatinib—Hypersensitivity—Triamcinolone—atopic dermatitis	7.01e-05	0.000253	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.99e-05	0.000252	CcSEcCtD
Dasatinib—Diarrhoea—Hydrocortisone—atopic dermatitis	6.91e-05	0.000249	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—atopic dermatitis	6.86e-05	0.000247	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—atopic dermatitis	6.86e-05	0.000247	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	6.85e-05	0.000247	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—atopic dermatitis	6.84e-05	0.000247	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—atopic dermatitis	6.83e-05	0.000246	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—atopic dermatitis	6.82e-05	0.000246	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—atopic dermatitis	6.82e-05	0.000246	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—atopic dermatitis	6.82e-05	0.000246	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—atopic dermatitis	6.82e-05	0.000246	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—atopic dermatitis	6.81e-05	0.000246	CcSEcCtD
Dasatinib—Insomnia—Prednisone—atopic dermatitis	6.8e-05	0.000245	CcSEcCtD
Dasatinib—TESK1—Dexamethasone—Hydrocortisone—atopic dermatitis	6.79e-05	0.00956	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Hydrocortisone—atopic dermatitis	6.79e-05	0.00956	CbGdCrCtD
Dasatinib—Pruritus—Triamcinolone—atopic dermatitis	6.73e-05	0.000243	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—atopic dermatitis	6.72e-05	0.000242	CcSEcCtD
Dasatinib—Dizziness—Hydrocortisone—atopic dermatitis	6.68e-05	0.000241	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—atopic dermatitis	6.62e-05	0.000239	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—atopic dermatitis	6.54e-05	0.000236	CcSEcCtD
Dasatinib—Rash—Prednisolone—atopic dermatitis	6.52e-05	0.000235	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—atopic dermatitis	6.52e-05	0.000235	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—atopic dermatitis	6.5e-05	0.000234	CcSEcCtD
Dasatinib—Fatigue—Prednisone—atopic dermatitis	6.48e-05	0.000234	CcSEcCtD
Dasatinib—Headache—Prednisolone—atopic dermatitis	6.48e-05	0.000234	CcSEcCtD
Dasatinib—Constipation—Prednisone—atopic dermatitis	6.43e-05	0.000232	CcSEcCtD
Dasatinib—Vomiting—Hydrocortisone—atopic dermatitis	6.42e-05	0.000232	CcSEcCtD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—atopic dermatitis	6.41e-05	0.00902	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—atopic dermatitis	6.41e-05	0.00902	CbGdCrCtD
Dasatinib—Rash—Hydrocortisone—atopic dermatitis	6.37e-05	0.00023	CcSEcCtD
Dasatinib—Dermatitis—Hydrocortisone—atopic dermatitis	6.36e-05	0.00023	CcSEcCtD
Dasatinib—Headache—Hydrocortisone—atopic dermatitis	6.33e-05	0.000228	CcSEcCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—atopic dermatitis	6.31e-05	0.00888	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—atopic dermatitis	6.31e-05	0.00888	CbGdCrCtD
Dasatinib—Dizziness—Triamcinolone—atopic dermatitis	6.29e-05	0.000227	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—atopic dermatitis	6.28e-05	0.000226	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—atopic dermatitis	6.2e-05	0.000223	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—atopic dermatitis	6.19e-05	0.000223	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—atopic dermatitis	6.19e-05	0.000223	CcSEcCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—atopic dermatitis	6.16e-05	0.00867	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Triamcinolone—atopic dermatitis	6.16e-05	0.00867	CbGdCrCtD
Dasatinib—Gastrointestinal pain—Prednisone—atopic dermatitis	6.15e-05	0.000222	CcSEcCtD
Dasatinib—Nausea—Prednisolone—atopic dermatitis	6.15e-05	0.000222	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—atopic dermatitis	6.11e-05	0.00022	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—atopic dermatitis	6.11e-05	0.00022	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—atopic dermatitis	6.05e-05	0.000218	CcSEcCtD
Dasatinib—Vomiting—Methylprednisolone—atopic dermatitis	6.04e-05	0.000218	CcSEcCtD
Dasatinib—Nausea—Hydrocortisone—atopic dermatitis	6e-05	0.000216	CcSEcCtD
Dasatinib—Rash—Triamcinolone—atopic dermatitis	6e-05	0.000216	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—atopic dermatitis	5.99e-05	0.000216	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—atopic dermatitis	5.99e-05	0.000216	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—atopic dermatitis	5.98e-05	0.000216	CcSEcCtD
Dasatinib—Urticaria—Prednisone—atopic dermatitis	5.97e-05	0.000215	CcSEcCtD
Dasatinib—Headache—Triamcinolone—atopic dermatitis	5.96e-05	0.000215	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—atopic dermatitis	5.95e-05	0.000215	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—atopic dermatitis	5.94e-05	0.000214	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—atopic dermatitis	5.94e-05	0.000214	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—atopic dermatitis	5.91e-05	0.000213	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—atopic dermatitis	5.91e-05	0.000213	CcSEcCtD
Dasatinib—TESK1—Dexamethasone—Prednisone—atopic dermatitis	5.85e-05	0.00823	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—atopic dermatitis	5.85e-05	0.00823	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisolone—atopic dermatitis	5.71e-05	0.00803	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—atopic dermatitis	5.71e-05	0.00803	CbGdCrCtD
Dasatinib—Dizziness—Betamethasone—atopic dermatitis	5.71e-05	0.000206	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—atopic dermatitis	5.71e-05	0.000206	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—atopic dermatitis	5.65e-05	0.000204	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—atopic dermatitis	5.64e-05	0.000203	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—atopic dermatitis	5.54e-05	0.0002	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—atopic dermatitis	5.49e-05	0.000198	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—atopic dermatitis	5.49e-05	0.000198	CcSEcCtD
Dasatinib—Rash—Dexamethasone—atopic dermatitis	5.44e-05	0.000196	CcSEcCtD
Dasatinib—Rash—Betamethasone—atopic dermatitis	5.44e-05	0.000196	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—atopic dermatitis	5.44e-05	0.000196	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—atopic dermatitis	5.44e-05	0.000196	CcSEcCtD
Dasatinib—Headache—Dexamethasone—atopic dermatitis	5.41e-05	0.000195	CcSEcCtD
Dasatinib—Headache—Betamethasone—atopic dermatitis	5.41e-05	0.000195	CcSEcCtD
Dasatinib—Asthenia—Prednisone—atopic dermatitis	5.39e-05	0.000195	CcSEcCtD
Dasatinib—Pruritus—Prednisone—atopic dermatitis	5.32e-05	0.000192	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—atopic dermatitis	5.14e-05	0.000186	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—atopic dermatitis	5.13e-05	0.000185	CcSEcCtD
Dasatinib—Nausea—Betamethasone—atopic dermatitis	5.13e-05	0.000185	CcSEcCtD
Dasatinib—Dizziness—Prednisone—atopic dermatitis	4.97e-05	0.000179	CcSEcCtD
Dasatinib—Vomiting—Prednisone—atopic dermatitis	4.78e-05	0.000172	CcSEcCtD
Dasatinib—Rash—Prednisone—atopic dermatitis	4.74e-05	0.000171	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—atopic dermatitis	4.74e-05	0.000171	CcSEcCtD
Dasatinib—Headache—Prednisone—atopic dermatitis	4.71e-05	0.00017	CcSEcCtD
Dasatinib—Nausea—Prednisone—atopic dermatitis	4.47e-05	0.000161	CcSEcCtD
Dasatinib—LCK—Signaling Pathways—IL5—atopic dermatitis	7.88e-06	3.05e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—IL2—atopic dermatitis	7.86e-06	3.05e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—MAPK8—atopic dermatitis	7.85e-06	3.04e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NGF—atopic dermatitis	7.83e-06	3.03e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD8A—atopic dermatitis	7.8e-06	3.02e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NFKBIA—atopic dermatitis	7.8e-06	3.02e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL10—atopic dermatitis	7.77e-06	3.01e-05	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—IL6—atopic dermatitis	7.75e-06	3e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GLB1—atopic dermatitis	7.7e-06	2.98e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CD4—atopic dermatitis	7.69e-06	2.98e-05	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—IL6—atopic dermatitis	7.69e-06	2.98e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CASP8—atopic dermatitis	7.68e-06	2.98e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL10—atopic dermatitis	7.67e-06	2.97e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IFNG—atopic dermatitis	7.66e-06	2.97e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL1B—atopic dermatitis	7.65e-06	2.96e-05	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—atopic dermatitis	7.63e-06	2.95e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL2—atopic dermatitis	7.62e-06	2.95e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CCR5—atopic dermatitis	7.61e-06	2.95e-05	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—atopic dermatitis	7.53e-06	2.92e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CASP8—atopic dermatitis	7.52e-06	2.91e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TAC1—atopic dermatitis	7.5e-06	2.91e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NPS—atopic dermatitis	7.5e-06	2.91e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CASP8—atopic dermatitis	7.48e-06	2.9e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CCR5—atopic dermatitis	7.44e-06	2.88e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NGF—atopic dermatitis	7.41e-06	2.87e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CASP8—atopic dermatitis	7.4e-06	2.87e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD4—atopic dermatitis	7.4e-06	2.87e-05	CbGpPWpGaD
Dasatinib—CSK—Disease—IL6—atopic dermatitis	7.39e-06	2.86e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD4—atopic dermatitis	7.39e-06	2.86e-05	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7.39e-06	2.86e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADSL—atopic dermatitis	7.38e-06	2.86e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—MAPK8—atopic dermatitis	7.36e-06	2.85e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCR3—atopic dermatitis	7.36e-06	2.85e-05	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—IL6—atopic dermatitis	7.35e-06	2.85e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—IL6—atopic dermatitis	7.29e-06	2.83e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IFNG—atopic dermatitis	7.25e-06	2.81e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NFKBIA—atopic dermatitis	7.23e-06	2.8e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CCR5—atopic dermatitis	7.21e-06	2.79e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL5—atopic dermatitis	7.21e-06	2.79e-05	CbGpPWpGaD
Dasatinib—STAT5B—Disease—IL6—atopic dermatitis	7.16e-06	2.77e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CASP8—atopic dermatitis	7.13e-06	2.76e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL5—atopic dermatitis	7.06e-06	2.73e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CASP8—atopic dermatitis	7.04e-06	2.73e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—MAPK8—atopic dermatitis	7.01e-06	2.72e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD4—atopic dermatitis	7e-06	2.71e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL5—atopic dermatitis	6.98e-06	2.7e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL5—atopic dermatitis	6.95e-06	2.69e-05	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—IL6—atopic dermatitis	6.88e-06	2.67e-05	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—IL6—atopic dermatitis	6.87e-06	2.66e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—NFKBIA—atopic dermatitis	6.83e-06	2.65e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL1B—atopic dermatitis	6.83e-06	2.65e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—CD4—atopic dermatitis	6.83e-06	2.65e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL2—atopic dermatitis	6.8e-06	2.64e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL10—atopic dermatitis	6.72e-06	2.6e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—CXCL8—atopic dermatitis	6.71e-06	2.6e-05	CbGpPWpGaD
Dasatinib—BTK—Immune System—IL6—atopic dermatitis	6.7e-06	2.59e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL5—atopic dermatitis	6.69e-06	2.59e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.68e-06	2.59e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NGF—atopic dermatitis	6.67e-06	2.59e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CXCL8—atopic dermatitis	6.66e-06	2.58e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL5—atopic dermatitis	6.6e-06	2.56e-05	CbGpPWpGaD
Dasatinib—SRC—Axon guidance—IL6—atopic dermatitis	6.6e-06	2.56e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CCR5—atopic dermatitis	6.59e-06	2.55e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NGF—atopic dermatitis	6.54e-06	2.53e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IFNG—atopic dermatitis	6.53e-06	2.53e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—MAPK8—atopic dermatitis	6.52e-06	2.52e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—IL6—atopic dermatitis	6.5e-06	2.52e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCR5—atopic dermatitis	6.49e-06	2.52e-05	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—IL6—atopic dermatitis	6.49e-06	2.52e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL1B—atopic dermatitis	6.47e-06	2.51e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CD4—atopic dermatitis	6.46e-06	2.5e-05	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—IL6—atopic dermatitis	6.46e-06	2.5e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NFKBIA—atopic dermatitis	6.46e-06	2.5e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL2—atopic dermatitis	6.44e-06	2.5e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NGF—atopic dermatitis	6.43e-06	2.49e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—IL2—atopic dermatitis	6.41e-06	2.48e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IFNG—atopic dermatitis	6.39e-06	2.48e-05	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—IL6—atopic dermatitis	6.39e-06	2.48e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL2—atopic dermatitis	6.37e-06	2.47e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IFNG—atopic dermatitis	6.36e-06	2.47e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PPARA—atopic dermatitis	6.36e-06	2.46e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCR5—atopic dermatitis	6.36e-06	2.46e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD4—atopic dermatitis	6.31e-06	2.44e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IFNG—atopic dermatitis	6.29e-06	2.44e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—MAPK8—atopic dermatitis	6.26e-06	2.43e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCR5—atopic dermatitis	6.26e-06	2.42e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NGF—atopic dermatitis	6.2e-06	2.4e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD4—atopic dermatitis	6.17e-06	2.39e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CASP8—atopic dermatitis	6.16e-06	2.39e-05	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—IL6—atopic dermatitis	6.15e-06	2.38e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD4—atopic dermatitis	6.15e-06	2.38e-05	CbGpPWpGaD
Dasatinib—HCK—Immune System—IL6—atopic dermatitis	6.14e-06	2.38e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NGF—atopic dermatitis	6.12e-06	2.37e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NFKBIA—atopic dermatitis	6.11e-06	2.37e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CXCL8—atopic dermatitis	6.09e-06	2.36e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CXCL8—atopic dermatitis	6.09e-06	2.36e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD4—atopic dermatitis	6.08e-06	2.36e-05	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—IL6—atopic dermatitis	6.08e-06	2.35e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IFNG—atopic dermatitis	6.06e-06	2.35e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—NFKBIA—atopic dermatitis	6.05e-06	2.34e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCR5—atopic dermatitis	6.03e-06	2.34e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IFNG—atopic dermatitis	5.98e-06	2.32e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCR5—atopic dermatitis	5.95e-06	2.31e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL10—atopic dermatitis	5.95e-06	2.3e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GLB1—atopic dermatitis	5.94e-06	2.3e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—MAPK8—atopic dermatitis	5.93e-06	2.3e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CXCL8—atopic dermatitis	5.87e-06	2.28e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MAPK8—atopic dermatitis	5.86e-06	2.27e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—IL6—atopic dermatitis	5.86e-06	2.27e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD4—atopic dermatitis	5.85e-06	2.27e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—atopic dermatitis	5.84e-06	2.26e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL1B—atopic dermatitis	5.82e-06	2.26e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CD4—atopic dermatitis	5.82e-06	2.26e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL2—atopic dermatitis	5.82e-06	2.26e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL2—atopic dermatitis	5.82e-06	2.25e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL2—atopic dermatitis	5.8e-06	2.25e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PPARA—atopic dermatitis	5.79e-06	2.24e-05	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—IL6—atopic dermatitis	5.79e-06	2.24e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL5—atopic dermatitis	5.78e-06	2.24e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD4—atopic dermatitis	5.78e-06	2.24e-05	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—IL6—atopic dermatitis	5.73e-06	2.22e-05	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—IL6—atopic dermatitis	5.71e-06	2.21e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL1B—atopic dermatitis	5.7e-06	2.21e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.7e-06	2.21e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL2—atopic dermatitis	5.68e-06	2.2e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL1B—atopic dermatitis	5.68e-06	2.2e-05	CbGpPWpGaD
Dasatinib—HCK—Disease—IL6—atopic dermatitis	5.67e-06	2.2e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL2—atopic dermatitis	5.65e-06	2.19e-05	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—IL6—atopic dermatitis	5.64e-06	2.19e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1B—atopic dermatitis	5.61e-06	2.18e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CD4—atopic dermatitis	5.61e-06	2.17e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL2—atopic dermatitis	5.61e-06	2.17e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.61e-06	2.17e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL2—atopic dermatitis	5.59e-06	2.17e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—IL6—atopic dermatitis	5.57e-06	2.16e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—IL6—atopic dermatitis	5.55e-06	2.15e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NFKBIA—atopic dermatitis	5.5e-06	2.13e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CASP8—atopic dermatitis	5.46e-06	2.11e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—IL6—atopic dermatitis	5.44e-06	2.11e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1B—atopic dermatitis	5.41e-06	2.09e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NFKBIA—atopic dermatitis	5.39e-06	2.09e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL2—atopic dermatitis	5.39e-06	2.09e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—IL6—atopic dermatitis	5.37e-06	2.08e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MAPK8—atopic dermatitis	5.36e-06	2.08e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NGF—atopic dermatitis	5.36e-06	2.08e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—MAPK8—atopic dermatitis	5.34e-06	2.07e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1B—atopic dermatitis	5.34e-06	2.07e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD4—atopic dermatitis	5.34e-06	2.07e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL2—atopic dermatitis	5.32e-06	2.06e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NFKBIA—atopic dermatitis	5.31e-06	2.06e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IFNG—atopic dermatitis	5.24e-06	2.03e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—MAPK8—atopic dermatitis	5.23e-06	2.03e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCR5—atopic dermatitis	5.21e-06	2.02e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—MAPK8—atopic dermatitis	5.21e-06	2.02e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL6—atopic dermatitis	5.18e-06	2.01e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MAPK8—atopic dermatitis	5.17e-06	2e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CXCL8—atopic dermatitis	5.15e-06	2e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—MAPK8—atopic dermatitis	5.15e-06	1.99e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL5—atopic dermatitis	5.12e-06	1.98e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NFKBIA—atopic dermatitis	5.11e-06	1.98e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL6—atopic dermatitis	5.1e-06	1.98e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—atopic dermatitis	5.06e-06	1.96e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NFKBIA—atopic dermatitis	5.04e-06	1.95e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—atopic dermatitis	5.01e-06	1.94e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—MAPK8—atopic dermatitis	4.96e-06	1.92e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—atopic dermatitis	4.93e-06	1.91e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—MAPK8—atopic dermatitis	4.89e-06	1.9e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NGF—atopic dermatitis	4.74e-06	1.84e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—atopic dermatitis	4.71e-06	1.83e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—atopic dermatitis	4.71e-06	1.83e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—atopic dermatitis	4.7e-06	1.82e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—atopic dermatitis	4.67e-06	1.81e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—atopic dermatitis	4.67e-06	1.81e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—atopic dermatitis	4.66e-06	1.8e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—atopic dermatitis	4.64e-06	1.8e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR5—atopic dermatitis	4.61e-06	1.79e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CXCL8—atopic dermatitis	4.6e-06	1.78e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MAPK8—atopic dermatitis	4.53e-06	1.76e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—atopic dermatitis	4.48e-06	1.74e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—atopic dermatitis	4.48e-06	1.74e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NFKBIA—atopic dermatitis	4.42e-06	1.71e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—atopic dermatitis	4.4e-06	1.7e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CXCL8—atopic dermatitis	4.36e-06	1.69e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—MAPK8—atopic dermatitis	4.29e-06	1.66e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—atopic dermatitis	4.16e-06	1.61e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—atopic dermatitis	4.16e-06	1.61e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARA—atopic dermatitis	4.15e-06	1.61e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—atopic dermatitis	4.14e-06	1.6e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—atopic dermatitis	4.14e-06	1.6e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—atopic dermatitis	4.12e-06	1.6e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAPK8—atopic dermatitis	4.05e-06	1.57e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—atopic dermatitis	4e-06	1.55e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL8—atopic dermatitis	3.93e-06	1.52e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARA—atopic dermatitis	3.92e-06	1.52e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NFKBIA—atopic dermatitis	3.91e-06	1.52e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL8—atopic dermatitis	3.84e-06	1.49e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAPK8—atopic dermatitis	3.83e-06	1.49e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—MAPK8—atopic dermatitis	3.79e-06	1.47e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—atopic dermatitis	3.79e-06	1.47e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL8—atopic dermatitis	3.78e-06	1.47e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—atopic dermatitis	3.75e-06	1.45e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—atopic dermatitis	3.74e-06	1.45e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—atopic dermatitis	3.69e-06	1.43e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—atopic dermatitis	3.67e-06	1.42e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—atopic dermatitis	3.64e-06	1.41e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—atopic dermatitis	3.62e-06	1.4e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—atopic dermatitis	3.6e-06	1.39e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—atopic dermatitis	3.5e-06	1.35e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—atopic dermatitis	3.48e-06	1.35e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK8—atopic dermatitis	3.45e-06	1.34e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—atopic dermatitis	3.44e-06	1.33e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—atopic dermatitis	3.42e-06	1.33e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—atopic dermatitis	3.42e-06	1.33e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—atopic dermatitis	3.41e-06	1.32e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK8—atopic dermatitis	3.38e-06	1.31e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—atopic dermatitis	3.34e-06	1.29e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK8—atopic dermatitis	3.33e-06	1.29e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—atopic dermatitis	3.32e-06	1.29e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—atopic dermatitis	3.3e-06	1.28e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—atopic dermatitis	3.29e-06	1.27e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK8—atopic dermatitis	3.21e-06	1.24e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—atopic dermatitis	3.17e-06	1.23e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK8—atopic dermatitis	3.16e-06	1.23e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—atopic dermatitis	3.15e-06	1.22e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—atopic dermatitis	3.15e-06	1.22e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARA—atopic dermatitis	3.13e-06	1.21e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—atopic dermatitis	3.13e-06	1.21e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—atopic dermatitis	3.04e-06	1.18e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—atopic dermatitis	3.01e-06	1.17e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—atopic dermatitis	2.9e-06	1.12e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—atopic dermatitis	2.89e-06	1.12e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—atopic dermatitis	2.79e-06	1.08e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK8—atopic dermatitis	2.77e-06	1.07e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—atopic dermatitis	2.74e-06	1.06e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—atopic dermatitis	2.67e-06	1.03e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—atopic dermatitis	2.59e-06	1e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—atopic dermatitis	2.53e-06	9.79e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.5e-06	9.68e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK8—atopic dermatitis	2.45e-06	9.51e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—atopic dermatitis	2.45e-06	9.48e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—atopic dermatitis	2.42e-06	9.39e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—atopic dermatitis	2.24e-06	8.67e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—atopic dermatitis	2.21e-06	8.54e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—atopic dermatitis	2.16e-06	8.37e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—atopic dermatitis	2.13e-06	8.24e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—atopic dermatitis	2.05e-06	7.93e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—atopic dermatitis	2.02e-06	7.83e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.93e-06	7.47e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—atopic dermatitis	1.77e-06	6.86e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—atopic dermatitis	1.57e-06	6.07e-06	CbGpPWpGaD
